Dr. David Joel Korman, M.D. Psychiatry & Neurology - Psychiatry Medicare: Accepting Medicare Assignments Practice Location: 703 W Patten St, Mineola, TX 75773 Phone: 903-569-5409 Fax: 903-535-7384 |
News Archive
OncoMed Pharmaceuticals, Inc., a clinical-stage company developing novel therapeutics that target cancer stem cells, or tumor-initiating cells, today announced that patient dosing has begun in a Phase I clinical trial of OMP-54F28 in patients with advanced solid tumor cancers.
Researchers at the RIKEN Quantitative Biology Center and the University of Tokyo have developed a method to visualize cancer metastasis in whole organs at the single-cell level.
Max Neeman International, a leading Indian CRO, announced a partnership with Max Healthcare to open a Phase I/IIa clinical trial unit at Max Super Speciality Hospital, New Delhi, India. This proof of concept unit will allow Pharmaceutical, Biotech & Device companies the option to complete a critical part of the development process across multiple therapeutic areas quickly and with the highest quality.
New materials and new technologies offer opportunities to bring implant dentistry to more patients. Fiber-reinforced composite is a new material that promises advantages for use in oral and craniofacial applications as well as in orthopedics. Discovering how it responds to stress and strain can help gauge its usefulness.
› Verified 3 days ago